AstraZeneca
AZN
#43
Rank
โ‚ฌ268.44 B
Marketcap
173,16ย โ‚ฌ
Share price
-1.09%
Change (1 day)
28.26%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of December 2025 : โ‚ฌ4.86 Billion

According to AstraZeneca's latest financial reports the company has โ‚ฌ4.86 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ4.88 B-7.95%
2024-12-31โ‚ฌ5.30 B0.16%
2023-12-31โ‚ฌ5.30 B-8.92%
2022-12-31โ‚ฌ5.82 B3.02%
2021-12-31โ‚ฌ5.64 B-13.05%
2020-12-31โ‚ฌ6.49 B17.08%
2019-12-31โ‚ฌ5.54 B13.49%
2018-12-31โ‚ฌ4.88 B28.83%
2017-12-31โ‚ฌ3.79 B-31.3%
2016-12-31โ‚ฌ5.52 B-10.42%
2015-12-31โ‚ฌ6.16 B6.52%
2014-12-31โ‚ฌ5.78 B-19.19%
2013-12-31โ‚ฌ7.16 B15.25%
2012-12-31โ‚ฌ6.21 B-28.4%
2011-12-31โ‚ฌ8.68 B-2.33%
2010-12-31โ‚ฌ8.89 B11.71%
2009-12-31โ‚ฌ7.95 B153.38%
2008-12-31โ‚ฌ3.14 B-23.03%
2007-12-31โ‚ฌ4.08 B-29.93%
2006-12-31โ‚ฌ5.82 B38.55%
2005-12-31โ‚ฌ4.20 B8.29%
2004-12-31โ‚ฌ3.88 B23.68%
2003-12-31โ‚ฌ3.13 B-30.02%
2002-12-31โ‚ฌ4.48 B3.6%
2001-12-31โ‚ฌ4.32 B-8.41%
2000-12-31โ‚ฌ4.72 B44.65%
1999-12-31โ‚ฌ3.26 B13.64%
1998-12-31โ‚ฌ2.87 B183.13%
1997-12-31โ‚ฌ1.01 B-27.82%
1996-12-31โ‚ฌ1.40 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.04 B 250.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ9.77 B 100.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ12.70 B 161.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ6.55 B 34.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ6.16 B 26.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ8.86 B 82.06%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ3.23 B-33.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ15.44 B 217.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ9.05 B 85.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ3.76 B-22.59%๐Ÿ‡ฌ๐Ÿ‡ง UK